Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

ValiRx (VAL) Share Price

Price 0.135p on 27-10-2026 at 18:55:12
Change 0.00p 0%
Buy 0.14p
Sell 0.13p
Last Trade: Buy 730,721.00 at 0.1359p
Day's Volume: 5,080,360
Last Close: 0.135p
Open: 0.135p
ISIN: GB00BLH13C52
Day's Range 0.135p - 0.135p
52wk Range: 0.125p - 0.475p
Market Capitalisation: £1.78m
VWAP: 0.133542p
Shares in Issue: 1.32b

ValiRx (VAL) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 730,721 0.1359p Ordinary
15:25:29 - 27-Oct-26
Buy* 2,000 0.14p SI Trade
14:01:50 - 27-Oct-26
Sell* 20,000 0.13p SI Trade
14:01:50 - 27-Oct-26
Buy* 5,000 0.14p SI Trade
14:01:50 - 27-Oct-26
Sell* 2,177 0.13p SI Trade
14:01:50 - 27-Oct-26
Buy* 1,000,000 0.1363p Ordinary
12:48:20 - 27-Oct-26
Sell* 1,161,150 0.13p Ordinary
11:31:40 - 27-Oct-26
Sell* 200,000 0.13p Ordinary
11:27:51 - 27-Oct-26
Buy* 500,000 0.13649p Ordinary
10:16:55 - 27-Oct-26
Sell* 1,052,268 0.13p Ordinary
08:15:46 - 27-Oct-26
See more ValiRx trades

ValiRx (VAL) Share Price History

Time period:
to
Date Open High Low Close Volume
27th Oct 2026 (Tue) 0.135 0.135 0.135 0.135 5,080,360
26th Oct 2026 (Mon) 0.14 0.15 0.135 0.135 12,359,986
23rd Oct 2026 (Fri) 0.14 0.14 0.14 0.14 19,686,788
22nd Oct 2026 (Thu) 0.145 0.145 0.135 0.14 22,248,985
21st Oct 2026 (Wed) 0.175 0.195 0.145 0.145 318,841,996
20th Oct 2026 (Tue) 0.13 0.175 0.13 0.16 151,517,709
19th Oct 2026 (Mon) 0.13 0.13 0.13 0.13 3,869,934
16th Oct 2026 (Fri) 0.13 0.13 0.13 0.13 1,475,119
15th Oct 2026 (Thu) 0.13 0.13 0.13 0.13 732,182
14th Oct 2026 (Wed) 0.13 0.13 0.13 0.13 47,551
13th Oct 2026 (Tue) 0.135 0.135 0.13 0.13 949,496
12th Oct 2026 (Mon) 0.135 0.135 0.135 0.135 3,739,547
9th Oct 2026 (Fri) 0.135 0.135 0.135 0.135 3,778,754
8th Oct 2026 (Thu) 0.135 0.135 0.135 0.135 179,963
7th Oct 2026 (Wed) 0.135 0.135 0.135 0.135 1,664,378
6th Oct 2026 (Tue) 0.135 0.135 0.135 0.135 34,698
5th Oct 2026 (Mon) 0.135 0.135 0.135 0.135 3,004,457
2nd Oct 2026 (Fri) 0.135 0.135 0.135 0.135 969,096
1st Oct 2026 (Thu) 0.135 0.135 0.135 0.135 900,905
30th Sep 2026 (Wed) 0.125 0.135 0.125 0.135 6,149,045
29th Sep 2026 (Tue) 0.125 0.125 0.125 0.125 776,850
28th Sep 2026 (Mon) 0.125 0.125 0.125 0.125 4,208,795
See more ValiRx price history

ValiRx (VAL) Regulatory News

Date Source Headline
21st Oct 2026 7:00 am RNS Update on Ambrose Healthcare shareholding
15th Sep 2026 7:00 am RNS Half-year Financial Report
10th Aug 2026 7:00 am RNS Cytolytix Patent Update
17th Jul 2026 12:25 pm RNS Result of AGM, Warrants & Directorate Change
22nd Jun 2026 7:00 am RNS Conclusion of Evaluation with University of Dundee
22nd Jun 2026 7:00 am RNS Final Results & Notice of AGM
2nd Jun 2026 7:00 am RNS Conclusion of Evaluation with Stingray
1st Jun 2026 7:00 am RNS ValiRx Exercises Option on Evaluation Asset
27th May 2026 7:00 am RNS Cytolytix Patent Granted
21st May 2026 7:00 am RNS Result of Oversubscribed WRAP Retail Offer
See more ValiRx regulatory news

ValiRx (VAL) Share News

WINNERS & LOSERS: Mobico and Ashtead surge on takeover news

21st Oct 2026 10:58

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Wednesday. Read More

ValiRx subsidiary Cytolytix nears "significant" European patent win

10th Aug 2026 11:10

(Alliance News) - ValiRx PLC on Monday announced that the European Patent Office intends to grant a patent for "a key part" of majority-owned subsidiary Cytolytix Ltd's intellectual property portfolio. Read More

UK shareholder meetings calendar - next 7 days

10th Jul 2026 13:43

Read More

TRADING UPDATES: Maintel fundraising completes; ValiRx ends deal

22nd Jun 2026 14:22

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More

IN BRIEF: ValiRx subsidiary Cytolytix granted "core" European patent

27th May 2026 20:36

ValiRx PLC - London-based life science company - Majority-owned subsidiary Cytolytix Ltd has its European patent "Nanoparticle for Anti-Cancer Peptides and Uses Thereof" granted. Notes the patent forms a "key part" of Cytolytix's intellectual property portfolio. Says the grant of the patent boosts Cytolytix's IP position, and affirms investment in the platform developed over the last few years. Adds that it also strengthens the firm's ability to attract external investment and expands licensing and partnership opportunities. Read More

See more ValiRx news
FTSE 100 Latest
Value10,686.54
Change-80.79

Login to your account

Forgot Password?

Not Registered